• Loading stock data…

stock market

A High-Risk, High-Reward Biotech Stock Targeting NASH Cirrhosis

In this next article in our series on investing in NASH I want to jump to the other end of the spectrum. In "Investing In This Biotech Sector Could Triple Your Net Wealth In 3-Years" I painted a … [Read more...] about A High-Risk, High-Reward Biotech Stock Targeting NASH Cirrhosis

ADMA Enters Into $72.5 Million Loan Facility With Perceptive Advisors

Today ADMA Biologics (Nasdaq: ADMA) announced that they entered into a senior secured loan term facility with Perceptive Advisors for up to $72.5 million under 2 funding tranches. Let's get clarify … [Read more...] about ADMA Enters Into $72.5 Million Loan Facility With Perceptive Advisors

Bristol-Myers Squibb Positioned For Deep Penetration In the Multiple Myeloma Market

Introduction Bristol-Myers Squibb (NYSE: BMY) is a profitable global bio-pharmaceutical company targeting an array of serious diseases and unmet medical needs. Earlier this month BMY announced … [Read more...] about Bristol-Myers Squibb Positioned For Deep Penetration In the Multiple Myeloma Market

Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath

Overview Wednesday October 24th, 2018 the stock market was slashed across the board with the DOW erasing all its gains for the year and dripping red. The Nasdaq was hit with equal force. Comments from … [Read more...] about Potentially Lucrative Opportunities Amidst A Stock Market Bloodbath

Investing at A Young Age: How My First Two Stock Investments Tripled

By MS Author: Zane Foley “Invest in Apple, invest in Tesla,” these were the stocks people, parents and professors were telling me to invest in after working my first salary position after college; but … [Read more...] about Investing at A Young Age: How My First Two Stock Investments Tripled

VSTM Overaction to Black Box Label Creates Buying Opportunity

For months Verastem Oncology (VSTM) investors have been eagerly awaiting the FDA's decision on it's lead product Duvelisib; a PI3K-δ (delta) and PI3K-γ (gamma) inhibitor that was granted Orphan Drug … [Read more...] about VSTM Overaction to Black Box Label Creates Buying Opportunity